GeminIQ

LLY

ELI LILLY & Co
$1137.82previous close on: 9/16/2026

Company Information

Company Name
ELI LILLY & Co
CIK
CIK0000059478
Category
Large accelerated filer
Ticker: Exchange
LLY: NYSE
Fiscal Year End
December 31
Owner Organization
03 Life Sciences
SIC
2834
SIC Description
Pharmaceutical Preparations
Ticker
LLY

SEC filing data through

Insider Sentiment

Last purchase
2025-08-15
Last sale
2026-06-10
Shares purchased (TTM)
6,987
Shares sold (TTM)
3,680,282
Buy ratio (TTM)0.2%

Institutional Sentiment

As of
2026-03-31
Institutional shares owned
733,100,019
Shares outstanding
894,500,000
Ownership
81.96%
+0.34% Y/Y

Earnings Market Reaction

Filing date
2026-08-05
Price on filing date
—
1-month reaction
0.55%
3-month reaction
Pending
Drift continued8/11 (73%)
Faded / reversed3/11 (27%)
Export data

Balance Sheet

Values in millions ($)
Line item2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-30Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnTrend
Assets Current
Cash And Cash Equivalents At Carrying Value8,9505,2827,2689,7923,3763,0933,2683,3693,2242,4602,8192,381
Short Term Investments---122170127155149140126109113
Accounts Receivable Net Current20,08318,42917,76016,10714,17012,03711,00610,29511,0287,8869,0918,167
Other Receivables Net Current3,3922,7482,3953,3503,0351,9672,2701,7572,0512,1282,2462,197
Inventory Net16,79314,52913,74412,18011,0149,3117,5897,4606,4826,1025,7734,901
Prepaid Expense And Other Assets Current-----------5,248
Prepaid Expense Current15,36813,63314,31520,24918,02014,6548,3418,2517,1386,3495,541-
Other Assets Current862141472726972266135142139150-
Assets Current64,67254,83555,62962,07149,85441,26132,74031,41530,20425,18925,72723,007
Assets Noncurrent
Long Term Investments3,8563,1162,8022,8083,2073,2233,2163,2002,8783,0873,0522,692
Goodwill8,8496,1305,8985,8985,7715,7715,7705,7685,7684,9404,9404,085
Intangible Assets Net Excluding Goodwill18,1107,3746,5216,4475,9086,0126,1666,5376,6366,7626,9076,782
Deferred Income Tax Assets Net10,02811,3509,9598,9639,4278,5738,0017,3926,6555,6345,4774,575
Property Plant And Equipment Net29,28626,54024,67522,31620,53018,47417,10216,17214,82913,62412,91411,863
Other Assets Noncurrent7,4827,2316,9926,4326,2256,0755,7205,1224,9044,7084,9904,912
Assets142,283116,576112,476114,935100,92389,38978,71575,60771,87563,94464,00657,916
Liabilities Current
Debt Current7,0504,0001,6351,6335,7244,0165,1172,0745,1621,6526,9052,245
Accounts Payable Current6,1125,0295,3794,2624,0763,4423,2292,8872,9252,4742,5992,435
Employee Related Liabilities Current1,7981,3592,3751,9661,3031,1142,0941,7031,1688441,6501,233
Dividends Payable Current----1,34501,34601,17101,1690
Taxes Payable Current---9,4446,9586,176-----1,978
Other Liabilities Current11,6598,6998,4575,2155,0773,7706,3975,5804,2494,1993,2812,585
Liabilities Current47,74136,63435,22840,14139,02030,06828,37624,67427,12118,59827,29321,998
Long Term Debt Noncurrent47,85839,37040,86840,87434,18034,50028,52729,04523,73024,56018,32117,924
Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent----1,3451,3161,3011,4491,4201,4281,4391,312
Accrued Income Taxes Noncurrent5,4615,2895,8756,2945,6845,3714,0613,8793,4974,1893,8493,468
Other Liabilities Noncurrent7,3444,0853,9703,7772,3452,2883,4792,2392,4712,2712,2411,906
Liabilities Noncurrent60,66348,74450,71350,94443,55443,47436,06736,61231,11832,44825,84924,610
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
Common Stock Value588590590591592593592594594594594594
Additional Paid In Capital Common Stock7,1176,9217,3467,2327,0896,9107,4397,3407,2147,0107,2507,160
Retained Earnings Accumulated Deficit31,89329,51424,47022,25217,37615,10013,54513,62713,17812,55410,31210,310
Common Stock Shares Held In Employee Trust-3,013-3,013-3,013-3,013-3,013-3,013-3,013-3,013-3,013-3,013-3,013-3,013
Accumulated Other Comprehensive Income Loss Net Of Tax-2,761-2,833-2,880-3,206-3,716-3,775-4,322-4,275-4,379-4,300-4,327-3,785
Treasury Stock Common Value----63-55-50-50-33-33-33-44-45
Other Additional Capital551922---31-----
Stockholders Equity33,87931,19826,53523,79318,34915,84714,27214,32113,56212,89710,86411,307
Minority Interest---587682808174859287
Liabilities And Stockholders Equity142,283116,576112,476114,935100,92389,38978,71575,60771,87563,94464,00657,916
Allowance For Doubtful Accounts Receivable Current---221616151614141513
Common Stock Shares Authorized--3,200---3,200---3,200-
Common Stock Shares Issued--945---948---950-
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment13,103--12,41112,55412,147-11,81611,42811,235-10,768

Select a line item above to chart it.

Recent filings

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial

ELI LILLY & Co (LLY) — SEC Financial Statements & Analysis

ELI LILLY & Co (LLY) is a pharmaceutical preparations company, incorporated in IN. ELI LILLY & Co trades on NYSE as: LLY. ELI LILLY & Co (LLY)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-05. Based on that filing, ELI LILLY & Co carries a market cap of $1.07T, a P/E ratio of 40.01x, a P/B ratio of 31.55x, a P/S ratio of 13.42x, an enterprise value of $1.11T, and an EV/EBITDA multiple of 31.23x. On profitability, it posts a gross margin of 83.40%, an operating margin of 42.17%, a net margin of 33.53%, a Return on Equity (ROE) of 102.29%, a Return on Assets (ROA) of 21.97%, and a Return on Invested Capital (ROIC) of 38.89%. Per share, it reports EPS of $29.93, diluted EPS of $29.89, free cash flow per share of $31.47, and a dividend per share of $6.48. Over the trailing year, it posted revenue growth of 49.58% year-over-year, net income growth of 93.56% year-over-year, and EPS growth of 94.75% year-over-year. On the balance sheet, it maintains a current ratio of 1.35x, a quick ratio of 0.68x, working capital of $16.93B, a debt-to-equity ratio of 3.20x, a debt ratio of 0.76, free cash flow of $28.08B (TTM), and net debt of $45.96B. Figures sourced from SEC EDGAR.

Market Cap
$1.07T
P/E TTM
40.01x
EPS TTM
$29.93
P/B TTM
31.55x
ROE TTM
102.29%
ROA TTM
21.97%
Debt To Equity
3.20x
Free Cash Flow TTM
$28.08B
Net Revenue TTM Growth 1Y
49.58%

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is ELI LILLY & Co in?

ELI LILLY & Co (LLY) operates in the Pharmaceutical Preparations industry.

What exchange does LLY trade on?

ELI LILLY & Co (LLY) trades on the NYSE.

Where is ELI LILLY & Co incorporated?

ELI LILLY & Co is incorporated in IN.

When was ELI LILLY & Co (LLY)'s most recent SEC filing?

ELI LILLY & Co (LLY)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-05.

What is LLY's market cap?

ELI LILLY & Co (LLY) has a market capitalization of $1.07T as of 2026-06-30.

What is LLY's P/E ratio?

ELI LILLY & Co (LLY)'s trailing twelve month P/E ratio is 40.01x as of 2026-06-30.

What is LLY's EPS (earnings per share)?

ELI LILLY & Co (LLY)'s trailing twelve month EPS is $29.93 as of 2026-06-30.

What is LLY's ROE (return on equity)?

ELI LILLY & Co (LLY)'s trailing twelve month Return on Equity (ROE) is 102.29% as of 2026-06-30.

What is LLY's ROA (return on assets)?

ELI LILLY & Co (LLY)'s trailing twelve month Return on Assets (ROA) is 21.97% as of 2026-06-30.

What is LLY's ROIC (return on invested capital)?

ELI LILLY & Co (LLY)'s trailing twelve month Return on Invested Capital (ROIC) is 38.89% as of 2026-06-30.

What is LLY's EV/EBITDA?

ELI LILLY & Co (LLY)'s trailing twelve month EV/EBITDA is 31.23x as of 2026-06-30.

Wall Street's data.
Main Street's price.

Start 7-day free trial